W. Verbeek et al., SEROPREVALENCE OF HHV-8 ANTIBODIES IN HIV-POSITIVE HOMOSEXUAL MEN WITHOUT KAPOSIS-SARCOMA AND THEIR CLINICAL FOLLOW-UP, AJCP. American journal of clinical pathology, 109(6), 1998, pp. 778-783
Human herpesvirus 8 (HHV-8) has been associated with Kaposi's sarcoma
(KS). Because KS is most frequently seen in HIV-positive homosexual me
n, we retrospectively evaluated the seroprevalence of HHV-8 in this ri
sk group and compared the clinical history and clinical course of the
HHV-8-negative and HHV-8-positive groups. The study was performed by a
nalyzing banked serum samples from asymptomatic HIV-positive men. HHV-
8 seropositivity was determined by an indirect immunofluorescence test
. A total of 56% of patients (42/75) were seropositive for anti-HHV-8
IgG antibodies as opposed to 12% of 40 age-matched HIV-negative contro
ls. Median CD4 counts at study entry were significantly lower in the H
HV-8-positive group than in the HHV-8-negative group (520 vs 686); how
ever, the percentage decrease during a 30-month follow-up did not diff
er significantly. KS developed in two patients during follow-up; both
were HHV-8-positive and had CD4 counts of less than 200/mu L at the ti
me of clinical manifestation. One HHV-8-positive patient in whom AIDS
developed died of infectious complications. The longest follow-up in t
he HHV-8-positive cohort without development of KS was 81 months. We c
onclude that HHV-8 has a high seroprevalence in asymptomatic, homosexu
al, HIV-positive persons. An HHV-8 infection can precede the developme
nt of KS by many years. Immunosuppression below a certain threshold ma
y trigger the clinical manifestation of KS.